INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATMENT OF MDR TB

摘要

The present invention relates to the treatment of tuberculosis and / or multidrug-resistant tuberculosis with an inhalable pharmaceutical composition comprising interferon and at least one therapeutic agent selected from the group consisting of fluoroquinolones, aminoglycosides and nitroimidazoles. The present invention also relates to an inhalable pharmaceutical composition comprising interferon and at least one therapeutic agent selected from the group consisting of fluoroquinolones, aminoglycosides and nitroimidazoles.